Long-Term Oncological Outcome Comparison between Intermediate- and High-Dose Radioactive Iodine Ablation in Patients with Differentiated Thyroid Carcinoma: A Propensity Score Matching Study
Open Access
- 24 February 2021
- journal article
- research article
- Published by Wiley in International Journal of Endocrinology
- Vol. 2021, 1-10
Abstract
Background. Radioactive iodine (RAI) ablation is recommended for most patients with differentiated thyroid carcinoma (DTC) after total thyroidectomy (TT). We aimed to compare long-term outcomes between intermediate-dose (100 mCi) and high-dose (150 mCi) RAI ablation therapy in patients with DTC using propensity score matching analysis. Methods. This was a retrospective study of 1448 patients with DTC who underwent RAI ablation after TT. Propensity score matching was performed using the extent of operation, tumor size, extrathyroidal extension, multifocality, lymphatic invasion, vascular invasion, perineural invasion, number of positive lymph nodes (LNs), ATA risk stratification system, T stage, N stage, TNM stage, preoperative serum Tg and TgAb levels, and post-RAI serum Tg and TgAb levels. Results. Recurrence rates in the intermediate- and high-dose groups were 3.1% and 5.6%, respectively. After propensity score matching, LN ratio >0.22 (HR, 2.915; 95% CI, 1.228–6.918; ) and serum Tg >10 ng/mL after RAI (HR, 3.976; 95% CI, 1.839–8.595; ) were significant predictors of recurrence. Kaplan–Meier analysis showed no significant difference in DFS before or after propensity score matching ( and , respectively). Conclusions. Intermediate-dose RAI ablation for the adjuvant treatment of DTC is sufficient as compared to high-dose RAI ablation. Further prospective or multicenter studies should be conducted to clarify the prognosis of intermediate-dose RAI ablation.Keywords
Funding Information
- Ministry of Education (NRF-2015R1D1A1A01058798)
This publication has 36 references indexed in Scilit:
- Association between screening and the thyroid cancer “epidemic” in South Korea: evidence from a nationwide studyBMJ, 2016
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016
- Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma – A systematic reviewCancer Treatment Reviews, 2015
- Current Thyroid Cancer Trends in the United StatesJAMA Otolaryngology–Head & Neck Surgery, 2014
- Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk FactorsJournal of Cancer Epidemiology, 2013
- Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registrySurgery, 2010
- Complications of Radioactive Iodine Treatment of Thyroid CarcinomaJournal of the National Comprehensive Cancer Network, 2010
- Increasing Incidence of Thyroid Cancer in the United States, 1973-2002JAMA, 2006
- Contemporary management of thyroid cancerAmerican Journal of Otolaryngology, 2005
- Thyroid Cancer: Is the Incidence Still Increasing?Annals of Surgical Oncology, 2004